BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2026 6:19:13 AM | Browse: 4 | Download: 1
 |
Received |
|
2025-07-23 02:30 |
|
Peer-Review Started |
|
2025-07-23 02:30 |
|
First Decision by Editorial Office Director |
|
2025-08-01 09:33 |
|
Return for Revision |
|
2025-08-01 09:33 |
|
Revised |
|
2025-08-13 16:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-02 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-02 22:34 |
|
Articles in Press |
|
2026-02-02 22:34 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-27 07:07 |
|
Publish the Manuscript Online |
|
2026-03-15 06:19 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maha Bouziane, Omar Moufid and Rachida Habbal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maha Bouziane, Assistant Professor, cardiology department, Ibn Rochd university Hospital of Casablanca, Corresponding author. Tel: 00212522482020/(P.269), Email: <email>mahabouziane@gmail.com</email>, Casablanca 20000, Casablanca-Settat, Morocco. mahabouziane@gmail.com |
| Key Words |
Cardiac amyloidosis; Light chains; Transthyretin; Diagnosis; Treatment |
| Core Tip |
This review highlights recent advances in cardiac amyloidosis (CA), a progressive infiltrative cardiomyopathy caused by amyloid fibril deposition in cardiac tissues. Improved recognition through advanced non-invasive imaging techniques and significant progress in disease-modifying therapies have transformed diagnosis and treatment. A multimodal diagnostic strategy and early identification are critical to improving patient outcomes. The review emphasizes the need for standardized diagnostic algorithms, increased clinical awareness, and a multidisciplinary approach to optimize care for patients with CA. |
| Publish Date |
2026-03-15 06:19 |
| Citation |
Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270 |
| URL |
https://www.wjgnet.com/2220-315x/full/v16/i1/112270.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v16.i1.112270 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
